scholarly article | Q13442814 |
P356 | DOI | 10.1038/NRENDO.2015.218 |
P698 | PubMed publication ID | 26729037 |
P50 | author | Heli Siljander | Q40817740 |
Mikael Knip | Q47161413 | ||
P2860 | cites work | Metabolic reconstruction for metagenomic data and its application to the human microbiome | Q21092513 |
Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome | Q21132451 | ||
CAMERA: a community resource for metagenomics | Q21145892 | ||
The metagenomics RAST server - a public resource for the automatic phylogenetic and functional analysis of metagenomes | Q21284200 | ||
The COG database: an updated version includes eukaryotes | Q21284294 | ||
SmashCommunity: a metagenomic annotation and analysis tool | Q24489693 | ||
Enterotypes of the human gut microbiome | Q24489818 | ||
Metagenomic microbial community profiling using unique clade-specific marker genes | Q24599864 | ||
Human gut microbiome viewed across age and geography | Q24602950 | ||
Linking long-term dietary patterns with gut microbial enterotypes | Q24609914 | ||
QIIME allows analysis of high-throughput community sequencing data | Q24616873 | ||
A human gut microbial gene catalogue established by metagenomic sequencing | Q24618931 | ||
The Pfam protein families database | Q24619716 | ||
Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis | Q24620719 | ||
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa | Q24622141 | ||
Toward defining the autoimmune microbiome for type 1 diabetes | Q24629032 | ||
KEGG for representation and analysis of molecular networks involving diseases and drugs | Q24644514 | ||
The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity | Q24645048 | ||
Innate immunity and intestinal microbiota in the development of Type 1 diabetes | Q24647312 | ||
Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities | Q24647611 | ||
The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics | Q24655377 | ||
De novo assembly of human genomes with massively parallel short read sequencing | Q24655711 | ||
Velvet: algorithms for de novo short read assembly using de Bruijn graphs | Q24657623 | ||
MEGAN analysis of metagenomic data | Q24673516 | ||
SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB | Q24685829 | ||
Breastfeeding and allergy: the evidence | Q26822025 | ||
Infant nutrition and later health: a review of current evidence | Q26822415 | ||
Human milk composition: nutrients and bioactive factors | Q26822855 | ||
Type 1 diabetes | Q27000491 | ||
Interactions between the microbiota and the immune system | Q27028155 | ||
Utilizing novel diversity estimators to quantify multiple dimensions of microbial biodiversity across domains | Q27496201 | ||
Effect of barrier microbes on organ-based inflammation | Q27693228 | ||
Diversity, stability and resilience of the human gut microbiota | Q28274959 | ||
Environmental triggers and determinants of type 1 diabetes | Q28283357 | ||
Development of intestinal microbiota in infants and its impact on health | Q28283698 | ||
Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans | Q36248024 | ||
ConStrains identifies microbial strains in metagenomic datasets | Q36364571 | ||
MetaVelvet: an extension of Velvet assembler to de novo metagenome assembly from short sequence reads | Q36368703 | ||
Host remodeling of the gut microbiome and metabolic changes during pregnancy | Q36421887 | ||
Xenobiotics shape the physiology and gene expression of the active human gut microbiome | Q36554412 | ||
Fecal microbiota composition differs between children with β-cell autoimmunity and those without | Q36720600 | ||
A molecular basis for bifidobacterial enrichment in the infant gastrointestinal tract | Q36830447 | ||
Gender bias in autoimmunity is influenced by microbiota. | Q37294725 | ||
Fecal microbiota imbalance in Mexican children with type 1 diabetes | Q37501593 | ||
Modeling the impact of antibiotic exposure on human microbiota | Q37629657 | ||
Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice. | Q37664261 | ||
Development of the human gastrointestinal microbiota and insights from high-throughput sequencing | Q37870427 | ||
Is the origin of type 1 diabetes in the gut? | Q37980043 | ||
Techniques used to characterize the gut microbiota: a guide for the clinician. | Q37997281 | ||
The 'Hygiene hypothesis' and the sharp gradient in the incidence of autoimmune and allergic diseases between Russian Karelia and Finland | Q38057812 | ||
Meta'omic analytic techniques for studying the intestinal microbiome | Q38184190 | ||
The role of infant nutrition in the prevention of future disease. | Q38237658 | ||
Removal of Bovine Insulin From Cow's Milk Formula and Early Initiation of Beta-Cell Autoimmunity in the FINDIA Pilot Study | Q38475105 | ||
The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis? | Q41326181 | ||
Vertical mother-neonate transfer of maternal gut bacteria via breastfeeding | Q42618067 | ||
Taxonomic metagenome sequence assignment with structured output models | Q42790557 | ||
Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. | Q43067512 | ||
Pathogenesis of type 1 diabetes: implications for incidence trends | Q43791624 | ||
The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design | Q45185347 | ||
Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice | Q46787541 | ||
Compromised gut microbiota networks in children with anti-islet cell autoimmunity | Q46922105 | ||
High temporal and inter-individual variation detected in the human ileal microbiota | Q48064015 | ||
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. | Q48516420 | ||
The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. | Q51221306 | ||
Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. | Q51369994 | ||
A maternal gluten-free diet reduces inflammation and diabetes incidence in the offspring of NOD mice. | Q53059497 | ||
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. | Q54468190 | ||
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. | Q55066037 | ||
Sex differences in autoimmune disease | Q55970264 | ||
Incidence of Type 1 Diabetes in Finland | Q56637647 | ||
Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood | Q56968869 | ||
Standard of hygiene and immune adaptation in newborn infants | Q57197922 | ||
Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice | Q57782997 | ||
Altered early infant gut microbiota in children developing allergy up to 5 years of age | Q58590854 | ||
Potential role of the intestinal microbiota of the mother in neonatal immune education | Q61940998 | ||
Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk | Q62587873 | ||
Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse | Q68153040 | ||
Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort | Q73795603 | ||
Genetic control of diabetes progression | Q74045636 | ||
The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study | Q74619069 | ||
Influence of mother's intestinal microbiota on gut colonization in the infant | Q85064465 | ||
The impact of perinatal immune development on mucosal homeostasis and chronic inflammation | Q95421092 | ||
The gut microbiota--masters of host development and physiology | Q28286102 | ||
From lifetime to evolution: timescales of human gut microbiota adaptation | Q28652725 | ||
Bacterial community comparisons by taxonomy-supervised analysis independent of sequence alignment and clustering | Q28740773 | ||
Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB | Q29547254 | ||
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns | Q29547261 | ||
Bacterial community variation in human body habitats across space and time | Q29547432 | ||
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences | Q29615050 | ||
Environmental biodiversity, human microbiota, and allergy are interrelated | Q30052290 | ||
Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section | Q30221761 | ||
Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. | Q30763625 | ||
Exposure to environmental microorganisms and childhood asthma | Q31000265 | ||
Cohabiting family members share microbiota with one another and with their dogs | Q31115660 | ||
IMG/M: a data management and analysis system for metagenomes | Q31132895 | ||
Cesarean delivery may affect the early biodiversity of intestinal bacteria | Q33361901 | ||
Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults | Q33464636 | ||
Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers | Q33497510 | ||
Developmental microbial ecology of the neonatal gastrointestinal tract | Q33610632 | ||
Relating the metatranscriptome and metagenome of the human gut. | Q33730723 | ||
Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. | Q33786301 | ||
The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions | Q33833767 | ||
The methylome of the gut microbiome: disparate Dam methylation patterns in intestinal Bacteroides dorei | Q33914240 | ||
Comparison of the gut microbiotas of healthy adult twins living in South Korea and the United States | Q34004511 | ||
Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes | Q34063601 | ||
Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change | Q34082845 | ||
The 'hygiene hypothesis' for autoimmune and allergic diseases: an update | Q34111851 | ||
Diabetes and gender | Q34155817 | ||
Compositional and functional features of the gastrointestinal microbiome and their effects on human health | Q34274976 | ||
Optimizing read mapping to reference genomes to determine composition and species prevalence in microbial communities | Q34311700 | ||
Evaluation of 16S rDNA-based community profiling for human microbiome research | Q34312366 | ||
Gut metagenome in European women with normal, impaired and diabetic glucose control | Q34347521 | ||
The function of our microbiota: who is out there and what do they do? | Q34392557 | ||
Groundtruthing next-gen sequencing for microbial ecology-biases and errors in community structure estimates from PCR amplicon pyrosequencing | Q34412286 | ||
Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study | Q34431258 | ||
MOCAT: a metagenomics assembly and gene prediction toolkit | Q34452175 | ||
The gut microbiota modulates glycaemic control and serum metabolite profiles in non-obese diabetic mice | Q34497283 | ||
Dietary Intervention in Infancy and Later Signs of Beta-Cell Autoimmunity | Q34567034 | ||
FANTOM: Functional and taxonomic analysis of metagenomes | Q34572424 | ||
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study | Q34596660 | ||
Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes | Q34668698 | ||
Human milk glycobiome and its impact on the infant gastrointestinal microbiota | Q34714658 | ||
Meta-analyses of studies of the human microbiota | Q34824829 | ||
Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes | Q34996838 | ||
Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study | Q35043312 | ||
Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. | Q35105043 | ||
The intestinal microbiome in type 1 diabetes | Q35120481 | ||
Long term effect of gut microbiota transfer on diabetes development | Q35157830 | ||
The gut microbiota and its role in the development of allergic disease: a wider perspective | Q35158619 | ||
The placenta harbors a unique microbiome | Q35171983 | ||
Aberrant gut microbiota composition at the onset of type 1 diabetes in young children | Q35188386 | ||
Mode of delivery shapes gut colonization pattern and modulates regulatory immunity in mice | Q35192585 | ||
The impact of microbiota on brain and behavior: mechanisms & therapeutic potential | Q35201615 | ||
Fermentable fibres condition colon microbiota and promote diabetogenesis in NOD mice. | Q35207919 | ||
Conducting a microbiome study | Q35208886 | ||
The small intestine microbiota, nutritional modulation and relevance for health | Q35325485 | ||
The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study | Q35371094 | ||
Peritoneal cavity is a route for gut-derived microbial signals to promote autoimmunity in non-obese diabetic mice | Q35437815 | ||
The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies | Q35539468 | ||
The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes | Q35557877 | ||
Helsinki alert of biodiversity and health | Q35612185 | ||
Sequencing and beyond: integrating molecular 'omics' for microbial community profiling | Q35615383 | ||
Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes | Q35661927 | ||
Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal | Q35920996 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | type-1 diabetes | Q124407 |
P304 | page(s) | 154-167 | |
P577 | publication date | 2016-01-04 | |
P1433 | published in | Nature Reviews Endocrinology | Q2079257 |
P1476 | title | The role of the intestinal microbiota in type 1 diabetes mellitus | |
P478 | volume | 12 |
Q104111154 | A bioengineering perspective on modelling the intestinal epithelial physiology in vitro |
Q36898152 | A microfluidics-based in vitro model of the gastrointestinal human-microbe interface |
Q41836455 | Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial |
Q46734564 | Alteration of Gut Microbiota and Inflammatory Cytokine/Chemokine Profiles in 5-Fluorouracil Induced Intestinal Mucositis |
Q46451309 | Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State |
Q36277657 | Antibiotics, gut microbiota, environment in early life and type 1 diabetes. |
Q47603984 | Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity |
Q61806595 | Association of prevalent vaginal microbiome of mother with occurrence of type I diabetes in child |
Q97425095 | Bioinspired oral delivery of gut microbiota by self-coating with biofilms |
Q92132360 | Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment |
Q40067457 | Bone Remodeling and the Microbiome. |
Q60950163 | Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes |
Q89737539 | Changes in Intestinal Microbiota Are Associated with Islet Function in a Mouse Model of Dietary Vitamin A Deficiency |
Q92833857 | Circulating metabolites in progression to islet autoimmunity and type 1 diabetes |
Q89529414 | Controversial Roles of Gut Microbiota-Derived Short-Chain Fatty Acids (SCFAs) on Pancreatic β-Cell Growth and Insulin Secretion |
Q61812173 | Cord-Blood Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes |
Q39427195 | Diabetes-induced mechanophysiological changes in the small intestine and colon |
Q36277135 | Differences in gut microbiota profile between women with active lifestyle and sedentary women. |
Q48244211 | Early life origin of type 1 diabetes |
Q33854613 | Early prediction of autoimmune (type 1) diabetes |
Q26741457 | Effect of Associated Autoimmune Diseases on Type 1 Diabetes Mellitus Incidence and Metabolic Control in Children and Adolescents |
Q51736799 | Elevated Fecal pH Indicates a Profound Change in the Breastfed Infant Gut Microbiome Due to Reduction of Bifidobacterium over the Past Century. |
Q90290369 | Environmental Factors Associated With Type 1 Diabetes |
Q92154990 | Epigenetic Regulation in Etiology of Type 1 Diabetes Mellitus |
Q58603842 | Evaluation of different mucosal microbiota leads to gut microbiota-based prediction of type 1 diabetes in NOD mice |
Q40132867 | Fatty is not that bad: feeding short-chain fatty acids to restrain autoimmunity |
Q57006877 | Fiber Supplements Derived From Sugarcane Stem, Wheat Dextrin and Psyllium Husk Have Different Effects on the Human Gut Microbiota |
Q92340565 | Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology |
Q64993094 | Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life. |
Q38932726 | Gnotobiotic mouse model's contribution to understanding host-pathogen interactions. |
Q92702188 | Greening of Daycare Yards with Biodiverse Materials Affords Well-Being, Play and Environmental Relationships |
Q55039606 | Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo. |
Q51144461 | Gut Microbiota and Type 1 Diabetes. |
Q64235692 | Gut Microbiota, a Potential New Target for Chinese Herbal Medicines in Treating Diabetes Mellitus |
Q52643740 | Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders. |
Q88916668 | Gut Microbiota: FFAR Reaching Effects on Islets |
Q57136925 | Gut microbiome in type 1 diabetes: A comprehensive review |
Q98726635 | Gut microbiota and diabetes: From correlation to causality and mechanism |
Q58119415 | Gut microbiota and plasma metabolites associated with diabetes in women with, or at high risk for, HIV infection |
Q58599426 | Gut microbiota-derived D-serine protects against acute kidney injury |
Q52632498 | Half-lives of PAHs and temporal microbiota changes in commonly used urban landscaping materials. |
Q47385058 | Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective |
Q47140307 | ISN Forefronts Symposium 2015: IgA Nephropathy, the Gut Microbiota, and Gut−Kidney Crosstalk. |
Q38835088 | Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation |
Q39095965 | Incidence of type 1 diabetes has doubled in Kuwaiti children 0-14 years over the last 20 years |
Q38795235 | Infant Feeding and Risk of Type 1 Diabetes in Two Large Scandinavian Birth Cohorts |
Q56525706 | Intestinal Dysbiosis in Autoimmune Diabetes Is Correlated With Poor Glycemic Control and Increased Interleukin-6: A Pilot Study |
Q48298448 | Intestinal alkaline phosphatase at the crossroad of intestinal health and disease - a putative role in type 1 diabetes. |
Q40127622 | Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children |
Q38767617 | Intraportal islet transplantation: the impact of the liver microenvironment |
Q40631825 | Is there a role for gut microbiota in type 1 diabetes pathogenesis? |
Q92641663 | Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes |
Q37578742 | MAHMI database: a comprehensive MetaHit-based resource for the study of the mechanism of action of the human microbiota |
Q57116726 | Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy |
Q39056719 | Measuring the diversity of the human microbiota with targeted next-generation sequencing |
Q38869770 | Mechanisms and consequences of intestinal dysbiosis. |
Q46033129 | Metabolomics in Diabetic Kidney Disease: Unraveling the Biochemistry of a Silent Killer. |
Q47396427 | Metabolomics reveals new metabolic perturbations in children with type 1 diabetes |
Q58711688 | Metagenomic Approaches for Understanding New Concepts in Microbial Science |
Q37733052 | Micro RNA-19a suppresses interleukin-10 in peripheral B cells of patients with diabetic retinopathy |
Q93138379 | Microbiome and type 1 diabetes |
Q37621587 | Microbiome sharing between children, livestock and household surfaces in western Kenya |
Q54237931 | Mining the Virome for Insights into Type 1 Diabetes. |
Q92650448 | Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice |
Q46301789 | Modulation of Type 1 Diabetes Risk by the Intestinal Microbiome |
Q47199753 | Old Fashioned vs. Ultra-Processed-Based Current Diets: Possible Implication in the Increased Susceptibility to Type 1 Diabetes and Celiac Disease in Childhood |
Q38898139 | On the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota |
Q49627122 | Perspectives on Systems Modeling of Human Peripheral Blood Mononuclear Cells |
Q50075636 | Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases. |
Q60047622 | Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome |
Q48177243 | Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics. |
Q36243299 | Role of intestinal microbiota and metabolites on gut homeostasis and human diseases |
Q99711430 | Role of the PD-1/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 Diabetes |
Q38951451 | Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour |
Q37662549 | Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research |
Q36951811 | Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics |
Q89365112 | TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells |
Q28078235 | Targeting gut microbiota: a potential promising therapy for diabetic kidney disease |
Q48047320 | The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis |
Q33577793 | The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies |
Q55100740 | The Ramazzini Institute 13-week pilot study on glyphosate and Roundup administered at human-equivalent dose to Sprague Dawley rats: effects on the microbiome. |
Q52315444 | The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into "Old" Diseases. |
Q38927461 | The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis |
Q48003839 | The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse |
Q90168466 | The heterogeneous pathogenesis of type 1 diabetes mellitus |
Q57807205 | The human gut microbiome in early-onset type 1 diabetes from the TEDDY study |
Q59358597 | The influence of the intestinal microbiome on vaccine responses |
Q39386100 | The multiple pathways to autoimmunity |
Q58773667 | Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes |
Q38952668 | Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases |
Q49200196 | Type 1 Diabetes: A Chronic Anti-Self-Inflammatory Response |
Q92982823 | Type 1 Diabetes: Disease Stratification |
Q91622714 | Type 1 Diabetes: an Association Between Autoimmunity, the Dynamics of Gut Amyloid-producing E. coli and Their Phages |
Q38774900 | Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota |
Q38819625 | Use of antibiotics in childhood and risk of Type 1 diabetes: a population-based case-control study |
Q47842162 | Waking up from antibiotic sleep |
Q33363965 | Where genes meet environment-integrating the role of gut luminal contents, immunity and pancreas in type 1 diabetes |